BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
10 results:

  • 1. Conservative re-treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: We can hope, at least.
    Raffone A; Raimondo D; Rovero G; Travaglino A; Lopez G; Di Maio CM; Neola D; Raspollini A; Renzulli F; Filippelli A; Casadio P; Seracchioli R; Guida M
    Int J Gynaecol Obstet; 2024 May; 165(2):542-551. PubMed ID: 37772342
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of sentinel lymph node assessment on the outcomes of patients with advanced endometrial cancer: A meta-analysis.
    Yao H; Luo R; Tong R; Wei Y; Zheng K; Hu X
    Medicine (Baltimore); 2023 Apr; 102(15):e33465. PubMed ID: 37058063
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Embryonal Rhabdomyosarcoma of the uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
    Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
    Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
    An M; Duan H; Zhang Y
    J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
    Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
    Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical treatment of stage IB cervical cancer.
    Ungár L; Pálfalvi L; Tarnai L; Nechushkina V; Lintner B; Novák Z;
    Int J Gynecol Cancer; 2012 Nov; 22(9):1597-603. PubMed ID: 23051962
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays.
    Yao Y; Chen Y; Wang Y; Li X; Wang J; Shen D; Wei L
    Int J Gynaecol Obstet; 2010 Aug; 110(2):125-9. PubMed ID: 20471643
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Obesity and prognosis in endometrial cancer.
    Anderson B; Connor JP; Andrews JI; Davis CS; Buller RE; Sorosky JI; Benda JA
    Am J Obstet Gynecol; 1996 Apr; 174(4):1171-8; discussion 1178-9. PubMed ID: 8623844
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.